(Q79149161)
Statements
The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR (English)
J Pfisterer
A du Bois
J Sehouli
S Loibl
S Reinartz
A Reuss
U Canzler
A Belau
C Jackisch
R Kimmig
K Wollschlaeger
V Heilmann